These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26726140)
1. [Intestinal fatty acid binding protein: marker of enterocyte damage in acute and chronic gastroenterological diseases]. Kocsis D; Papp M; Tornai T; Tulassay Z; Herszényi L; Tóth M; Juhász M Orv Hetil; 2016 Jan; 157(2):59-64. PubMed ID: 26726140 [TBL] [Abstract][Full Text] [Related]
2. The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases. Ho SSC; Keenan JI; Day AS Dig Dis Sci; 2020 Feb; 65(2):376-390. PubMed ID: 31529416 [TBL] [Abstract][Full Text] [Related]
3. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. Schaart MW; de Bruijn AC; Bouwman DM; de Krijger RR; van Goudoever JB; Tibboel D; Renes IB J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):31-41. PubMed ID: 19458550 [TBL] [Abstract][Full Text] [Related]
4. Gut mucosal cell damage in meningococcal sepsis in children: relation with clinical outcome. Derikx JP; Bijker EM; Vos GD; van Bijnen AA; Heineman E; Buurman WA; van Waardenburg DA Crit Care Med; 2010 Jan; 38(1):133-7. PubMed ID: 19730255 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers of gut barrier failure in the ICU. Piton G; Capellier G Curr Opin Crit Care; 2016 Apr; 22(2):152-60. PubMed ID: 26808138 [TBL] [Abstract][Full Text] [Related]
6. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. Derikx JP; Vreugdenhil AC; Van den Neucker AM; Grootjans J; van Bijnen AA; Damoiseaux JG; van Heurn LW; Heineman E; Buurman WA J Clin Gastroenterol; 2009 Sep; 43(8):727-33. PubMed ID: 19359998 [TBL] [Abstract][Full Text] [Related]
7. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. Schurink M; Kooi EM; Hulzebos CV; Kox RG; Groen H; Heineman E; Bos AF; Hulscher JB PLoS One; 2015; 10(3):e0121336. PubMed ID: 25793701 [TBL] [Abstract][Full Text] [Related]
8. [Early diagnostic value of plasma and urine concentration of Intestinal fatty acid binding protein in gastrointestinal dysfunction or failure in the critically ill children]. Wang F; Zhu BQ; Xu D Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):712-3. PubMed ID: 18021569 [No Abstract] [Full Text] [Related]
9. Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621 [TBL] [Abstract][Full Text] [Related]
10. Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine. Gajda AM; Storch J Prostaglandins Leukot Essent Fatty Acids; 2015 Feb; 93():9-16. PubMed ID: 25458898 [TBL] [Abstract][Full Text] [Related]
11. Intestinal fatty acid-binding protein levels in Necrotizing Enterocolitis correlate with extent of necrotic bowel: results from a multicenter study. Heida FH; Hulscher JB; Schurink M; Timmer A; Kooi EM; Bos AF; Bruggink JL; Kasper DC; Pones M; Benkoe T J Pediatr Surg; 2015 Jul; 50(7):1115-8. PubMed ID: 25783297 [TBL] [Abstract][Full Text] [Related]
12. Intestinal fatty acid-binding protein: a possible marker for gut maturation. Reisinger KW; Elst M; Derikx JP; Nikkels PG; de Vries B; Adriaanse MP; Jellema RK; Kramer BW; Wolfs TG Pediatr Res; 2014 Sep; 76(3):261-8. PubMed ID: 24956227 [TBL] [Abstract][Full Text] [Related]
13. Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Piton G; Belon F; Cypriani B; Regnard J; Puyraveau M; Manzon C; Navellou JC; Capellier G Crit Care Med; 2013 Sep; 41(9):2169-76. PubMed ID: 23782971 [TBL] [Abstract][Full Text] [Related]
14. Temporal profile of intestinal tissue expression of intestinal fatty acid-binding protein in a rat model of necrotizing enterocolitis. Simões AL; Figueira RL; Gonçalves FL; Mitidiero LF; Silva OC; Peiró JL; Sbragia L Clinics (Sao Paulo); 2016 Jul; 71(7):412-9. PubMed ID: 27464299 [TBL] [Abstract][Full Text] [Related]
15. Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease. Gross S; Adriaanse MP; Nijeboer P; Tack GJ; van Hoogstraten IM; Bouma G; Mulder CJ; von Blomberg BM; Vreugdenhil AC; Bontkes HJ J Gastrointestin Liver Dis; 2015 Jun; 24(2):258-9. PubMed ID: 26114190 [No Abstract] [Full Text] [Related]
16. [Acute mesenteric ischemia: do biomarkers contribute to diagnosis?]. Rosero O; Harsányi L; Szijártó A Orv Hetil; 2014 Oct; 155(41):1615-23. PubMed ID: 25282106 [TBL] [Abstract][Full Text] [Related]
17. Smooth muscle actin as a novel serologic marker of severe intestinal damage in rat intestinal ischemia-reperfusion and human necrotising enterocolitis. Evennett N; Cerigioni E; Hall NJ; Pierro A; Eaton S J Surg Res; 2014 Oct; 191(2):323-30. PubMed ID: 24909869 [TBL] [Abstract][Full Text] [Related]
18. Enterocyte fatty acid uptake and intestinal fatty acid-binding protein. Tso P; Nauli A; Lo CM Biochem Soc Trans; 2004 Feb; 32(Pt 1):75-8. PubMed ID: 14748716 [TBL] [Abstract][Full Text] [Related]